Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation.
Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Legaz I, Muro M, García-Alonso AM, Martínez-Sánchez MV, Moral JM, Pascual-Figal DA, Alvarez-López MR, Miras M, Minguela A. Blanco-García RM, et al. Hum Immunol. 2011 Oct;72(10):841-8. doi: 10.1016/j.humimm.2011.06.004. Epub 2011 Jun 22. Hum Immunol. 2011. PMID: 21742001
Association of monoclonal expansion of Epstein-Barr virus-negative CD158a+ NK cells secreting large amounts of gamma interferon with hemophagocytic lymphohistiocytosis.
López-Alvarez MR, Martínez-Sánchez MV, Salgado-Cecilia MG, Campillo JA, Heine-Suñer D, Villar-Permuy F, Fuster JL, Bas A, Gil-Herrera J, Muro M, García-Alonso AM, Alvarez-López MR, Minguela A. López-Alvarez MR, et al. Clin Vaccine Immunol. 2009 Jan;16(1):142-5. doi: 10.1128/CVI.00358-08. Epub 2008 Nov 19. Clin Vaccine Immunol. 2009. PMID: 19020108 Free PMC article.
Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.
Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Gimeno L, Muro M, García-Alonso AM, Martínez-Sánchez MV, Bernardo Pisa MV, Soriano-Díaz S, Pascual-Figal DA, Alvarez-López MR, Minguela A. Blanco-García RM, et al. Hum Immunol. 2013 Mar;74(3):318-24. doi: 10.1016/j.humimm.2012.12.001. Epub 2012 Dec 14. Hum Immunol. 2013. PMID: 23247208
Comparison of Two Types of Liquid Biopsies in Patients With Hepatocellular Carcinoma Awaiting Orthotopic Liver Transplantation.
Sánchez-Lorencio MI, Ramirez P, Saenz L, Martínez Sánchez MV, De La Orden V, Mediero-Valeros B, Veganzones-De-Castro S, Baroja-Mazo A, Revilla Nuin B, Gonzalez MR, Cascales-Campos PA, Noguera-Velasco JA, Minguela A, Díaz-Rubio E, Pons JA, Parrilla P. Sánchez-Lorencio MI, et al. Transplant Proc. 2015 Nov;47(9):2639-42. doi: 10.1016/j.transproceed.2015.10.003. Transplant Proc. 2015. PMID: 26680058
Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.
Martínez-Sánchez MV, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros NR, Campillo JA, Bolarin JM, Bernardo MV, López-Álvarez MR, González C, García-Garay MC, Muro M, Cabañas-Perianes V, Fuster JL, García-Alonso AM, Moraleda JM, Álvarez-Lopez MR, Minguela A. Martínez-Sánchez MV, et al. Oncoimmunology. 2015 Oct 29;5(4):e1093721. doi: 10.1080/2162402X.2015.1093721. eCollection 2016 Apr. Oncoimmunology. 2015. PMID: 27141379 Free PMC article.
Circulating aberrant plasma cells allows risk stratification of patients with myeloma.
Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A. Periago A, et al. Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24. Am J Hematol. 2016. PMID: 27220360 Free article. No abstract available.
NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome.
Guillamón CF, Martínez-Sánchez MV, Gimeno L, Mrowiec A, Martínez-García J, Server-Pastor G, Martínez-Escribano J, Torroba A, Ferri B, Abellán D, Campillo JA, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Cancer Immunol Res. 2018 Dec;6(12):1537-1547. doi: 10.1158/2326-6066.CIR-18-0022. Epub 2018 Sep 21. Cancer Immunol Res. 2018. PMID: 30242020
Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance.
Guillamón CF, Martínez-Sánchez MV, Gimeno L, Campillo JA, Server-Pastor G, Martínez-García J, Martínez-Escribano J, Torroba A, Ferri B, Abellán DJ, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Cancer Immunol Res. 2019 Aug;7(8):1307-1317. doi: 10.1158/2326-6066.CIR-18-0847. Epub 2019 Jun 25. Cancer Immunol Res. 2019. PMID: 31239317
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers.
Guillamón CF, Gimeno L, Server G, Martínez-Sánchez MV, Escudero JF, López-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martínez-García J, Martínez-Escribano J, Ferri B, López-Álvarez MR, Moreno-Alarcón C, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Among authors: martinez sanchez mv. Eur Urol Oncol. 2021 Apr;4(2):246-255. doi: 10.1016/j.euo.2019.04.009. Epub 2019 May 14. Eur Urol Oncol. 2021. PMID: 31411976
KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling.
Gimeno L, Serrano-López EM, Campillo JA, Cánovas-Zapata MA, Acuña OS, García-Cózar F, Martínez-Sánchez MV, Martínez-Hernández MD, Soto-Ramírez MF, López-Cubillana P, Martínez-Escribano J, Martínez-García J, Corbalan-García S, Álvarez-López MR, Minguela A. Gimeno L, et al. Among authors: martinez sanchez mv. Cancers (Basel). 2020 Oct 15;12(10):2991. doi: 10.3390/cancers12102991. Cancers (Basel). 2020. PMID: 33076479 Free PMC article.
18 results